Skip to content

Testing of indigenous electrocorticography electrodes

Validation of indigenously developed, biocompatibility and safety proven Electrocorticography electrodesâ??

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/12/029538
Enrollment
10
Registered
2020-12-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G402- Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

Interventions

Intervention1: ECOG signal quality recorded by indigenously developed electrodes: During the surgery patient will undergo electrocorticography i.e. recording of the electrical potentials directly from

Sponsors

Society for biomedical technology SBMT
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 18-55 years, Refractory epilepsy (Failure of seizures to respond to adequate therapy with at least two standard antiepileptic drugs) Planned for epilepsy surgery with ECOG by the treating team Willingness to participate

Exclusion criteria

Exclusion criteria: History of head injury or neurosurgery No indication for ECOG Not willing to participate

Design outcomes

Primary

MeasureTime frame
To assess the ECOG signal quality of indigenously developed electrodes in comparison with commercially available electrodesTimepoint: 1year

Secondary

MeasureTime frame
NATimepoint: NA

Countries

India

Contacts

Public ContactSanjib Sinha

National Institute of Mental Health and Neuro Sciences (NIMHANS)

sanjib_sinha2004@yahoo.co.in9480829407

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026